Chang Hyeon Kong , Keontae Park , Ju Eun Han , Ho Jung Bae , Se Jin Park , Seo Yun Jung , Dong Hyun Kim , Jong Hoon Ryu
{"title":"Sinapic acid balances the excitatory and inhibitory neurotransmitter systems to mitigate post-traumatic stress disorder-like behaviors","authors":"Chang Hyeon Kong , Keontae Park , Ju Eun Han , Ho Jung Bae , Se Jin Park , Seo Yun Jung , Dong Hyun Kim , Jong Hoon Ryu","doi":"10.1016/j.lfs.2026.124201","DOIUrl":null,"url":null,"abstract":"<div><div>Post-traumatic stress disorder (PTSD) is a mental illness that can occur in individuals who have experienced trauma. Sinapic acid has been reported to be effective for anxiety as a GABA<sub>A</sub> receptor agonist, and has been reported to improve cognitive impairment by modulating the GABA/glutamate ratio, but there are no reports associated with PTSD. In the present study, we investigated the effects of sinapic acid in a mouse model of PTSD induced by a single prolonged stress (SPS) protocol.</div><div>We examined the therapeutic effects of sinapic acid on emotional and cognitive impairment in the SPS mouse model. We also explored the effects of sinapic acid on fear memory extinction. Western blot was employed to investigate how sinapic acid exerts its pharmacological activities.</div><div>Sinapic acid ameliorated PTSD-like behaviors in a SPS mouse model. Notably, in the case of cognitive dysfunction, paroxetine failed to improve, but sinapic acid restored cognitive function. Additionally, sinapic acid did not increase locomotor behavior, while paroxetine increased. Furthermore, sinapic acid normalized the overactivated GluN2B-containing NMDA receptor signaling pathway in the amygdala and the hypothalamus. The mitigation of fear memory deficits by sinapic acid was exerted by sub-effective dose of GluN2B-containing NMDA receptor antagonist and abolished by GABA<sub>A</sub> receptor antagonist.</div><div>Our findings suggest that sinapic acid could serve as a potential therapeutic agent for PTSD by balancing excitatory and inhibitory neurotransmitter systems due to its action on GluN2B-containing NMDA receptors and GABA<sub>A</sub> receptors.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"388 ","pages":"Article 124201"},"PeriodicalIF":6.4000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320526000093","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Post-traumatic stress disorder (PTSD) is a mental illness that can occur in individuals who have experienced trauma. Sinapic acid has been reported to be effective for anxiety as a GABAA receptor agonist, and has been reported to improve cognitive impairment by modulating the GABA/glutamate ratio, but there are no reports associated with PTSD. In the present study, we investigated the effects of sinapic acid in a mouse model of PTSD induced by a single prolonged stress (SPS) protocol.
We examined the therapeutic effects of sinapic acid on emotional and cognitive impairment in the SPS mouse model. We also explored the effects of sinapic acid on fear memory extinction. Western blot was employed to investigate how sinapic acid exerts its pharmacological activities.
Sinapic acid ameliorated PTSD-like behaviors in a SPS mouse model. Notably, in the case of cognitive dysfunction, paroxetine failed to improve, but sinapic acid restored cognitive function. Additionally, sinapic acid did not increase locomotor behavior, while paroxetine increased. Furthermore, sinapic acid normalized the overactivated GluN2B-containing NMDA receptor signaling pathway in the amygdala and the hypothalamus. The mitigation of fear memory deficits by sinapic acid was exerted by sub-effective dose of GluN2B-containing NMDA receptor antagonist and abolished by GABAA receptor antagonist.
Our findings suggest that sinapic acid could serve as a potential therapeutic agent for PTSD by balancing excitatory and inhibitory neurotransmitter systems due to its action on GluN2B-containing NMDA receptors and GABAA receptors.
期刊介绍:
Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.